Get the Stockscreener App
3.73
1.36%
0.05
After Hours:
3.70
-0.03
-0.80%
Cingulate Inc stock is traded at $3.73, with a volume of 55,510.
It is up +1.36% in the last 24 hours and down -10.12% over the past month.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
See More
Previous Close:
$3.68
Open:
$3.63
24h Volume:
55,510
Relative Volume:
0.31
Market Cap:
$20.19M
Revenue:
-
Net Income/Loss:
$-21.21M
P/E Ratio:
-0.1144
EPS:
-32.6
Net Cash Flow:
$-16.86M
1W Performance:
-1.58%
1M Performance:
-10.12%
6M Performance:
-5.33%
1Y Performance:
+8.43%
1-Day Range:
$3.62
$3.755
1-Week Range:
$3.62
$3.905
52-Week Range:
$3.28
$6.01
Cingulate Inc Stock (CING) Company Profile
Name
Cingulate Inc
Sector
Industry
Phone
(913) 942-2300
Address
1901 W. 47TH PLACE, KANSAS CITY
Compare CING with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
3.73 | 20.63M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | ROTH MKM | Buy |
| Dec-22-23 | Downgrade | Laidlaw | Buy → Hold |
Cingulate Inc Stock (CING) Latest News
Why Cingulate Inc. stock remains on buy listsAnalyst Upgrade & Proven Capital Preservation Methods - newser.com
Strategies to average down on Cingulate Inc. Equity Warrant2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
Will Cingulate Inc. Equity Warrant stock recover faster than marketTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Signal strength of Cingulate Inc. stock in tech scannersJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
Trend analysis for Cingulate Inc. Equity Warrant this weekOil Prices & Capital Efficient Trading Techniques - newser.com
What data driven models say about Cingulate Inc.’s future2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Will a bounce in Cingulate Inc. offer an exitPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Will Cingulate Inc. stock beat EPS estimatesWeekly Trend Summary & High Accuracy Trade Signal Alerts - newser.com
Can Cingulate Inc. Equity Warrant stock continue upward trendJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Cingulate Inc. stock outperform value stocksJuly 2025 Earnings & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Published on: 2025-11-06 05:36:50 - newser.com
Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growthWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
Will Cingulate Inc. stock remain a Wall Street favorite2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
How supply chain issues affect Cingulate Inc. stockWeekly Risk Summary & Daily Price Action Insights - newser.com
Is now a turning point for Cingulate Inc.July 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Will breakout in Cingulate Inc. Equity Warrant lead to full recoveryMarket Movers & Consistent Growth Equity Picks - newser.com
Is Cingulate Inc. Equity Warrant meeting your algorithmic filter criteria2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com
Risk adjusted return profile for Cingulate Inc. Equity Warrant analyzed2025 Technical Overview & Accurate Intraday Trade Tips - newser.com
Why Cingulate Inc. stock is trending among retail traders2025 Historical Comparison & Real-Time Market Sentiment Alerts - fcp.pa.gov.br
Does Cingulate Inc. fit your quant trading modelJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Measuring Cingulate Inc. Equity Warrant’s beta against major indicesIndex Update & Low Drawdown Trading Techniques - newser.com
Combining price and volume data for Cingulate Inc.Portfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Published on: 2025-11-05 22:11:26 - newser.com
Will Cingulate Inc. Equity Warrant stock pay special dividendsWeekly Volume Report & AI Driven Price Predictions - newser.com
Real time breakdown of Cingulate Inc. stock performanceGap Up & Weekly Setup with High ROI Potential - newser.com
Can Cingulate Inc. stock resist market sell offsWeekly Stock Recap & Detailed Earnings Play Alerts - newser.com
How to use a screener to detect Cingulate Inc. breakoutsPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
Will Cingulate Inc. Equity Warrant stock benefit from AI adoptionDividend Hike & Fast Gain Stock Trading Tips - fcp.pa.gov.br
Is Cingulate Inc. Equity Warrant stock in correction or buying zoneVolume Spike & Daily Volume Surge Signals - newser.com
Can Cingulate Inc. stock deliver consistent earnings growthJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Is Cingulate Inc a good long term investmentEarnings Call Summaries & High Profit Portfolio Growth - earlytimes.in
Can technical indicators confirm Cingulate Inc. Equity Warrant’s reversalJuly 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com
Why Cingulate Inc. Equity Warrant stock appeals to analystsJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Why Cingulate Inc. stock remains on watchlistsProfit Target & Daily Technical Forecast Reports - newser.com
Cingulate Inc Stock (CING) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):